Sign in

CIK 0001434316

  • Non-accelerated filer
  • Smaller reporting company

FATE THERAPEUTICS INC

Sign in to watch
Ticker
FATE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
651311552
Phone
+1 858-875-1803
Business address
12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$13,525
in 1 filing

Net −$13,525. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Adawi Kamal −$14K Chief Financial Officer sold 7% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-07-21 Wolchko J Scott President and CEO Option exercise · Stock Option (Right to Buy) −30,000 6,246
2022-07-07 Valamehr Bahram Chief R&D Officer Option exercise +17,158 $2.73 $47K 196,992
2022-07-07 Valamehr Bahram Chief R&D Officer Sale −17,158 $30.23 $519K 179,834
2022-07-07 Valamehr Bahram Chief R&D Officer Option exercise · Stock Option (Right to Buy) −17,158 $2.73 $47K 13,156
2022-07-06 Valamehr Bahram Chief R&D Officer Option exercise +2,000 $4.84 $10K 181,834
2022-07-06 Valamehr Bahram Chief R&D Officer Option exercise +5,842 $2.73 $16K 187,676
2022-07-06 Valamehr Bahram Chief R&D Officer Sale −7,842 $30.07 $236K 179,834
2022-07-06 Valamehr Bahram Chief R&D Officer Option exercise · Stock Option (Right to Buy) −2,000 $4.84 $10K 8,704
2022-07-06 Valamehr Bahram Chief R&D Officer Option exercise · Stock Option (Right to Buy) −5,842 $2.73 $16K 30,314
2022-07-05 Plavsic Mark Chief Technical Officer Sale −3,719 $24.61 $92K 127,123
2022-06-27 Powl Brian T. Chief Commercial Officer Grant or award +45,000 45,000
2022-06-27 Powl Brian T. Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +70,000 70,000
2022-06-09 Xu Yuan Director Grant or award +8,650 13,394
2022-06-09 Xu Yuan Director Grant or award · Stock Option (Right to Buy) +11,893 11,893
2022-06-09 RASTETTER WILLIAM H Director Grant or award +8,650 11,331
2022-06-09 RASTETTER WILLIAM H Director Grant or award · Stock Option (Right to Buy) +11,893 11,893
2022-06-09 MENDLEIN JOHN Director Grant or award +8,650 166,741
2022-06-09 MENDLEIN JOHN Director Grant or award · Stock Option (Right to Buy) +11,893 11,893
2022-06-09 Jooss Karin Director Grant or award +8,650 9,848
2022-06-09 Jooss Karin Director Grant or award · Stock Option (Right to Buy) +11,893 11,893

Page 9 of 26 · 503 trades